Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | FLNAFilana Therapeutics, Inc.FY2013 · Dec |
|---|---|
| Revenue | $41.12M |
| Revenue, yoy | +277.6% |
| Net income | $90.97M |
| Net income, yoy | −273.7% |
| Net margin | — |
| Free cash flow | $32.83M |
| FCF margin | — |
| EPS, diluted | $1.88 |
Add another company.